Dr Mohammed Atari is a highly accomplished professional in biomedical engineering, mathematical modelling, and data science. He earned his BSc in biomedical engineering from Jordan University of Science and Technology and later achieved a first-class MSc in advanced biomedical engineering from the University of Warwick. Awarded the Vice Chancellor’s Scholarship, he completed his PhD in biomedical systems modelling in 2010, focusing on the kinetics and dynamics of the anti-cancer agent topotecan.
Dr Atari began his career at Cyprotex (now Evotec), where he progressed to Principal Mathematical Modeller, developing innovative machine learning (ML) models for drug absorption, distribution, metabolism, and toxicity. His contributions were recognised with the Institute of Physics and Engineering in Medicine’s Innovation Early Career Award in 2017. In 2021, he earned an MSc in statistics at Lancaster University, where he developed stochastic models to analyse COVID-19 transmission and vaccine impact.
Currently, Dr Atari is a Principal Non-Clinical PK/PD Scientist at UCB, a global biopharmaceutical company. With over 14 years of experience, he also delivers training courses in data science, machine learning, and statistics across various industries, including banking, healthcare, and pharmaceuticals. A Chartered Engineer (CEng) and Scientist (CSci), Dr Atari is committed to empowering organisations through advanced analytics.